Improve Medical Instruments Co., Ltd. (SZSE: 300030)
Health Care · Life Sciences Tools & Services · CN
CN¥6.83
-2.15% today · -22.6% 1Y
Improve Medical Instruments Co., Ltd. (SZSE: 300030) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $314.14M and employs 632 people.
Over the last twelve months the share price has lost 22.6%, trading between 5.61 and 9.00.
Tweenvest scores Improve Medical Instruments Co., Ltd. across four factors: quality 71/100, value 42/100, growth 33/100. Its strongest factor is quality.
300030 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $314.14M
- Revenue (TTM)
- $69.25M
- P/E
- 66.31
- EPS
- 0.10
- Dividend yield
- —
- Beta (5Y)
- 0.45
- 52-week high
- CN¥9.00
- 52-week low
- CN¥5.61
- Avg volume (3M)
- —
- Shares outstanding
- 309.19M
- Employees
- 632
- Next earnings
- —
About Improve Medical Instruments Co., Ltd.
Improve Medical Instruments Co., Ltd. operates as an international supplier, delivering advanced technologies, medical products, and critical services to clinical laboratories and for patient care, spanning both the Chinese market and global regions. A significant portion of its product portfolio comprises leading brands such as IMPROVACUTER evacuated blood collection systems, IMPROMINI capillary blood collection systems, IMPROSWAB microbiological transport systems, IMPRONURSE infusion and syringe pumps, and LONGX urine analysis platforms, alongside an assortment of in-vitro diagnostic reagents. Furthermore, the company's comprehensive offerings extend to a wide range of ancillary equipment and disposables, including blood collection needles, pulsewave blood pressure monitors, thrombosis viscoelastic analysis systems, feces analysis systems, automated blood and urine collection tube preparation systems, graphical user interface (GUI) devices, intelligent sorting units, multi-functional blood collection workstations, smart queue management systems, automatic tube packing systems, and consumable labels. Originally incorporated in 1996 as Guangzhou Improve Medical Instruments Co., Ltd., the enterprise maintains its headquarters in Guangzhou, China.
- ISIN
- CNE100000JL3
- Founded
- 1996
- Listed since
- Dec 25, 2009
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Thermo Fisher Scientific Inc.NYSE: TMO | $232.67B | $629.27 | +0.27% |
| Danaher CorporationNYSE: DHR | $153.85B | $218.85 | +1.36% |
| WuXi AppTec Co., Ltd.SHSE: 603259 | $72.12B | CN¥162.86 | -3.00% |
| Samsung Biologics Co.,Ltd.KOSE: A207940 | $51.75B | ₩1,551,000.00 | +0.19% |
| Lonza Group AGSWX: LONN | $51.61B | CHF592.20 | +1.09% |
| Agilent Technologies, Inc.NYSE: A | $44.91B | $159.00 | +1.73% |
| IQVIA Holdings Inc.NYSE: IQV | $42.77B | $259.82 | +1.47% |
| Waters CorporationNYSE: WAT | $40.35B | $410.70 | +1.49% |
Figures last refreshed Aug 18, 2026.